• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微流控技术辅助单分散固体脂质微球的颗粒工程制备:载药量均一且固体状态多样。

Microfluidics-enabled particle engineering of monodisperse solid lipid microparticles with uniform drug loading and diverse solid-state outcomes.

机构信息

Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117576, Singapore.

Matralix Pte Ltd, 71 Ayer Rajah Crescent, #07-05, Singapore 139951, Singapore.

出版信息

Int J Pharm. 2021 Mar 1;596:120230. doi: 10.1016/j.ijpharm.2021.120230. Epub 2021 Jan 21.

DOI:10.1016/j.ijpharm.2021.120230
PMID:33484918
Abstract

Lipids serve as excellent excipients for drug products. Solid lipid microparticles (SLMs) are relatively underexplored in drug delivery; these particles are conventionally prepared using processes yielding polydisperse size distributions, such as spray congealing or emulsification. In this paper, we demonstrate a microfluidics-enabled process for particle engineering of monodisperse solid lipid microparticles with size and content uniformity. To overcome low solubility, we use a volatile solvent to increase drug loading, making the drug-lipid solution a single phase, enabling identical drug loading across particles. We use microfluidic flow extrusion of the solution to generate uniform drug-loaded SLMs, substantially enhancing monodispersity. This method generalises across three drugs-ibuprofen, 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile (ROY), and naproxen, and two lipids-beeswax and hard fat (Suppocire NAI 25A), forming particles of various solid states: amorphous naproxen in crystalline lipids, crystalline ROY in crystalline lipids, and a eutectic mixture of ibuprofen-hard fat. In vitro dissolution studies on the ibuprofen-hard fat SLMs reveal gradual release, fitting the Higuchi model with 50-65% drug released over 72 h. This work expands the drug particle engineering toolbox to enable the formulation of SLMs with high precision in particle size and drug loading. Moreover, the diverse solid-state outcomes enabled by our method makes it applicable to various drugs having different formulation requirements (crystalline/amorphous).

摘要

脂质是药物产品的优良赋形剂。固体脂质微球 (SLM) 在药物传递中相对较少被探索;这些颗粒通常使用产生多分散粒径分布的工艺制备,例如喷雾凝固或乳化。在本文中,我们展示了一种基于微流控的方法,用于对单分散固体脂质微球进行颗粒工程改造,使其具有粒径和含量的均匀性。为了克服低溶解度的问题,我们使用挥发性溶剂来提高药物载药量,使药物-脂质溶液成为单相,从而实现颗粒间的相同药物载药量。我们使用溶液的微流控流延挤出法生成均匀的载药 SLM,从而大大提高了单分散性。这种方法适用于三种药物——布洛芬、5-甲基-2-[(2-硝基苯基)氨基]-3-噻吩甲腈 (ROY) 和萘普生,以及两种脂质——蜂蜡和硬脂 (Suppocire NAI 25A),形成各种固态的颗粒:结晶脂质中的无定形萘普生、结晶脂质中的结晶 ROY 以及布洛芬-硬脂的共晶混合物。体外布洛芬-硬脂 SLM 的溶解研究表明其具有逐渐释放的特点,符合 Higuchi 模型,72 小时内释放 50-65%的药物。这项工作扩展了药物颗粒工程工具包,使能够以高精度控制粒径和药物载药量来制备 SLM。此外,我们的方法所实现的多样化固态结果使其适用于具有不同制剂要求(结晶/无定形)的各种药物。

相似文献

1
Microfluidics-enabled particle engineering of monodisperse solid lipid microparticles with uniform drug loading and diverse solid-state outcomes.微流控技术辅助单分散固体脂质微球的颗粒工程制备:载药量均一且固体状态多样。
Int J Pharm. 2021 Mar 1;596:120230. doi: 10.1016/j.ijpharm.2021.120230. Epub 2021 Jan 21.
2
Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.基于 Eudragit E100 的疏水性药物的微流控颗粒工程─弥合无定形和结晶的差距。
Mol Pharm. 2022 Nov 7;19(11):4345-4356. doi: 10.1021/acs.molpharmaceut.2c00714. Epub 2022 Oct 21.
3
Determination of solid state characteristics of spray-congealed Ibuprofen solid lipid microparticles and their impact on sustaining drug release.喷雾冷凝法制备的布洛芬固体脂质微粒的固态特性测定及其对药物缓释的影响
Mol Pharm. 2015 May 4;12(5):1592-604. doi: 10.1021/acs.molpharmaceut.5b00015. Epub 2015 Apr 15.
4
Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.用固体脂质分散体制剂调节托彻普的药物释放并提高其口服生物利用度。
AAPS PharmSciTech. 2015 Oct;16(5):1091-100. doi: 10.1208/s12249-015-0299-8. Epub 2015 Feb 18.
5
Formulating SLMs as oral pulsatile system for potential delivery of melatonin to pediatric population.将 SLM 制成口服脉冲系统,以期将褪黑素递送给儿科人群。
Int J Pharm. 2014 Jul 20;469(1):67-79. doi: 10.1016/j.ijpharm.2014.04.055. Epub 2014 Apr 24.
6
Development of solid lipid microparticles by melt-emulsification/spray-drying processes as carriers for pulmonary drug delivery.通过熔融乳化/喷雾干燥工艺制备固体脂质微粒作为肺部药物递送载体
Eur J Pharm Sci. 2021 Jan 1;156:105588. doi: 10.1016/j.ejps.2020.105588. Epub 2020 Oct 10.
7
An investigation into the release behavior of solid lipid microparticles in different simulated gastrointestinal fluids.不同模拟胃肠道液中固体脂质微球的释放行为研究。
Colloids Surf B Biointerfaces. 2019 Jan 1;173:276-285. doi: 10.1016/j.colsurfb.2018.09.056. Epub 2018 Sep 26.
8
Solid lipid microparticles as a sustained release system for pulmonary drug delivery.固体脂质微粒作为肺部药物递送的缓释系统。
Eur J Pharm Biopharm. 2007 Jan;65(1):47-56. doi: 10.1016/j.ejpb.2006.07.006. Epub 2006 Jul 20.
9
Evaluation of spray congealing as technique for the preparation of highly loaded solid lipid microparticles containing the sunscreen agent, avobenzone.喷雾固化法制备高载药量含防晒剂阿伏苯宗固体脂质微球的评价。
J Pharm Sci. 2009 Aug;98(8):2759-69. doi: 10.1002/jps.21636.
10
Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.固体脂质微粒:制剂、制备、表征、药物释放及应用
Expert Opin Drug Deliv. 2005 Jan;2(1):75-87. doi: 10.1517/17425247.2.1.75.